TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19408475

Group type: EXPERIMENTAL
Intervention: Mineralized collagen bone substitute (MCBS) combined with recombinant human platelet-derived growth factor-BB (0.3 mg/mL)
Number of subjects: 7
Study: 17761236

Group type: EXPERIMENTAL
Intervention: Nutrition computer modules (oral rehydration therapy, calcium, and vitamins) on compact disc for study over 6 weeks
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 38
Study: 15119693

Group type: EXPERIMENTAL
Intervention: 80 mg atorvastatin
Number of subjects: 97

Group type: COMPARATOR
Intervention: 20 mg simvastatin
Number of subjects: 97
Study: 11766367

Group type: EXPERIMENTAL
Intervention: Leuprolide alone (group I)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Leuprolide and Estramustine (group II)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Estramustine alone (group III)
Number of subjects: 102
Study: 9489910

Group type: EXPERIMENTAL
Intervention: Jejunal pouch (Pouch group)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Roux-en-Y reconstruction (Roux-en-Y group)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Patients with severe dumping (compared to those without dumping)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Maximal hydrogen concentration in the glucose breath test
Number of subjects: 46
Study: 7848228

Group type: EXPERIMENTAL
Intervention: 15 mg prostaglandin F2 alpha (PGF2 alpha) applied intracervically
Number of subjects: 296

Group type: COMPARATOR
Intervention: Standard oxytocin intravenous infusion
Number of subjects: 296
Study: 2899425

Group type: EXPERIMENTAL
Intervention: Electroconvulsive treatments (ECTs)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Lithium carbonate
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both ECT and Lithium carbonate
Number of subjects: 34
Study: 31473019

Group type: EXPERIMENTAL
Intervention: Intravenous contrast exposure
Number of subjects: 0
Study: 29452259

Group type: EXPERIMENTAL
Intervention: AsthmaCare mobile application
Number of subjects: 193

Group type: COMPARATOR
Intervention: Control (online asthma information)
Number of subjects: 193
Study: 27903675

Group type: EXPERIMENTAL
Intervention: Neoadjuvant multiagent chemotherapy
Number of subjects: 63

Group type: COMPARATOR
Intervention: Endocrine therapy
Number of subjects: 63

Group type: COMPARATOR
Intervention: Adjuvant endocrine therapy only or no adjuvant systemic therapy
Number of subjects: 63

Group type: COMPARATOR
Intervention: (Neo)adjuvant chemotherapy
Number of subjects: 63
Study: 25820464

Group type: EXPERIMENTAL
Intervention: OSA-VC
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 22618308

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) program
Number of subjects: 90

Group type: COMPARATOR
Intervention: Wait-list control (Treatment as Usual - TAU)
Number of subjects: 90
Study: 21177797

Group type: EXPERIMENTAL
Intervention: 80 mg soy hypocotyl isoflavones
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: 120 mg soy hypocotyl isoflavones
Number of subjects: 403

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 403
Study: 18978622

Group type: EXPERIMENTAL
Intervention: Jaw clenching (JAW)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Non-jaw clenching (NON‐JAW)
Number of subjects: 14
Study: 16187969

Group type: EXPERIMENTAL
Intervention: BMT (bismuth biskalcitrate, metronidazole, tetracycline) in fed state
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: BMT (bismuth biskalcitrate, metronidazole, tetracycline) in fasting state
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: BMT (bismuth biskalcitrate, metronidazole, tetracycline) administered with food
Number of subjects: 23
Study: 12792359

Group type: EXPERIMENTAL
Intervention: Group drug counseling (GDC)
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Group counseling plus individual drug counseling (IDC)
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT)
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Supportive-expressive therapy (SE)
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Combination of IDC and GDC
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 487
Study: 10669989

Group type: EXPERIMENTAL
Intervention: Dual therapy (omeprazole 20 mg b.d. plus amoxycillin 1 g b.d.)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Triple therapy (omeprazole 20 mg b.d., clarithromycin 250 mg b.d., and tetracycline 500 mg b.d.)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Re-treatment with triple regimen
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Re-treatment with dual therapy
Number of subjects: 83
Study: 8549172

Group type: EXPERIMENTAL
Intervention: Development of new respiratory symptoms (dyspnea)
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: Development of new respiratory symptoms (wheeze)
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: Persistence of respiratory symptoms
Number of subjects: 446

Group type: COMPARATOR
Intervention: Initially reported symptoms
Number of subjects: 446
Study: 1985140

Group type: EXPERIMENTAL
Intervention: Physician reminders
Number of subjects: 7397

Group type: EXPERIMENTAL
Intervention: Patient reminders
Number of subjects: 7397

Group type: EXPERIMENTAL
Intervention: Both physician and patient reminders
Number of subjects: 7397

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 7397
Study: 6339026

Group type: EXPERIMENTAL
Intervention: Radical mastectomy plus internal mammary dissection
Number of subjects: 1453

Group type: COMPARATOR
Intervention: Radical mastectomy without internal mammary dissection
Number of subjects: 1453
Study: 30552829

Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine (0.075 mmol/kg)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Gadoterate meglumine (0.15 mmol/kg)
Number of subjects: 104
Study: 30316489

Group type: EXPERIMENTAL
Intervention: Audio-based cognitive behavioral therapy (ACBT)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Computer-based cognitive behavioral therapy (CCBT)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Delayed treatment control
Number of subjects: 51
Study: 26970112

Group type: EXPERIMENTAL
Intervention: License condition (self-licensing)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Control condition (no self-licensing)
Number of subjects: 218
Study: 25026919

Group type: EXPERIMENTAL
Intervention: Black chokeberry juice (156 mL per resident daily for 3 months in group A)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Black chokeberry juice (89 mL per resident daily for 3 months in group B)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Placebo drink (for 3 months in group A)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Placebo drink (for 3 months in group B)
Number of subjects: 236
Study: 22261573

Group type: EXPERIMENTAL
Intervention: HiCarb/LoProt diet (glucose 10 mg · kg(‐1) · min(‐1)/protein 0.7 g · kg(‐1) · d(‐1))
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: HiCarb/LoProt diet
Number of subjects: 24

Group type: COMPARATOR
Intervention: NormCarb/LoProt diet (glucose 7.5 mg · kg(‐1) · min(‐1)/protein 0.3 g · kg(‐1) · d(‐1))
Number of subjects: 24

Group type: COMPARATOR
Intervention: NormCarb/LoProt diet
Number of subjects: 24
Study: 20039931

Group type: EXPERIMENTAL
Intervention: High-dose tirofiban with enoxaparin
Number of subjects: 60

Group type: COMPARATOR
Intervention: High-dose tirofiban with unfractionated heparin (UFH)
Number of subjects: 60
Study: 17116121

Group type: EXPERIMENTAL
Intervention: Unannounced visits by standardized patients (SPs) portraying roles with major depression or adjustment disorder.
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: High suspicion visits
Number of subjects: 152

Group type: COMPARATOR
Intervention: HMO settings
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Standardized patients (SPs)
Number of subjects: 152
Study: 12702111

Group type: EXPERIMENTAL
Intervention: Teeth neighbouring cleft (site 1)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Tooth in cleft (site 2)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Contra-lateral teeth (sites 3 and 4)
Number of subjects: 75
Study: 10896692

Group type: EXPERIMENTAL
Intervention: EEG coherence analysis in patients with multiple sclerosis
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control subjects (22 subjects)
Number of subjects: 28
Study: 8816002

Group type: EXPERIMENTAL
Intervention: Health examination programme
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control group (no health examination)
Number of subjects: 124
Study: 1401823

Group type: EXPERIMENTAL
Intervention: Lactulose
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Lactitol
Number of subjects: 18
Study: 4058845

Group type: EXPERIMENTAL
Intervention: Honan intraocular pressure reducer (HIPR) applied for 40 minutes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Honan intraocular pressure reducer (HIPR) applied for 5 minutes
Number of subjects: 0
Study: 30469101

Group type: EXPERIMENTAL
Intervention: E‐STOPS (Electronic Support Tool and Orders for the Prevention of Smoking)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: E‐STOPS
Number of subjects: 126
Study: 30212434

Group type: EXPERIMENTAL
Intervention: On-demand HIV pre-exposure prophylaxis (PrEP)
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Chemsex
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: High-risk sexual practices
Number of subjects: 331
Study: 27648752

Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT) for SAD
Number of subjects: 20

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 20
Study: 25081864

Group type: COMPARATOR
Intervention: Catholic hospital
Number of subjects: 236

Group type: COMPARATOR
Intervention: Secular hospital
Number of subjects: 236

Group type: COMPARATOR
Intervention: Gynecologist care
Number of subjects: 236
Study: 22575023

Group type: EXPERIMENTAL
Intervention: Subsidiary support system initiated and coordinated by a dementia care manager (nurse with dementia-specific qualifications)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 20395096

Group type: EXPERIMENTAL
Intervention: Creatine monohydrate (5 g/day for 8 weeks)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo (500 mg of vitamin C)
Number of subjects: 33
Study: 18555812

Group type: EXPERIMENTAL
Intervention: 30 mcg ethinyl estradiol plus 3 mg drospirenone (Group A)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: 20 mcg ethinyl estradiol plus 3 mg drospirenone (Group B)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Healthy controls (Group C)
Number of subjects: 65
Study: 16003231

Group type: EXPERIMENTAL
Intervention: Tacrolimus (TAC)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Cyclosporine (CsA)
Number of subjects: 200
Study: 12484508

Group type: COMPARATOR
Intervention: CCB (amlodipine 5 mg once daily)
Number of subjects: 17

Group type: COMPARATOR
Intervention: ACE‐I (temocapril 2 mg once daily)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: ARB (candesartan 4 mg once daily) added to CCB
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: ARB (candesartan 4 mg once daily) added to ACE‐I
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: ARB plus ACE‐I
Number of subjects: 17
Study: 10717757

Group type: EXPERIMENTAL
Intervention: Amodiaquine 30 mg/kg
Number of subjects: 364

Group type: COMPARATOR
Intervention: Chloroquine 25 mg/kg
Number of subjects: 364
Study: 7491391

Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg of Methylphenidate (MPH)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 0.6 mg/kg of Methylphenidate (MPH)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 1834462

Group type: EXPERIMENTAL
Intervention: Isradipine (0.5 mg)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo (10 ml solvent)
Number of subjects: 23
Study: 7042357

Group type: EXPERIMENTAL
Intervention: Indoprofen (800 mg/day)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Indomethacin (100 mg/day)
Number of subjects: 97
Study: 30155870

Group type: EXPERIMENTAL
Intervention: Psoriasis (moderate or severe)
Number of subjects: 405078

Group type: COMPARATOR
Intervention: No psoriasis
Number of subjects: 405078
Study: 31090747

Group type: EXPERIMENTAL
Intervention: 0.5 mm subcrestal implant placement
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 1.5 mm subcrestal implant placement
Number of subjects: 60
Study: 28873376

Group type: EXPERIMENTAL
Intervention: 16 mg cathine
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: 32 mg cathine
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: 53.3 mg cathine
Number of subjects: 241

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 241
Study: 26445024

Group type: EXPERIMENTAL
Intervention: Kinesiology tape (KT) applied to the volar aspect of the dominant forearm
Number of subjects: 13

Group type: COMPARATOR
Intervention: No tape applied
Number of subjects: 13
Study: 23506844

Group type: EXPERIMENTAL
Intervention: Partially hydrolyzed whey formula (pHF-W)
Number of subjects: 2252

Group type: EXPERIMENTAL
Intervention: Extensively hydrolyzed whey formula (eHF-W)
Number of subjects: 2252

Group type: EXPERIMENTAL
Intervention: Extensively hydrolyzed casein formula (eHF-C)
Number of subjects: 2252

Group type: COMPARATOR
Intervention: Standard cow's milk formula
Number of subjects: 2252
Study: 21153030

Group type: EXPERIMENTAL
Intervention: Intravenous L: -arginine (10 g in 20 min)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (placebo and arginine)
Number of subjects: 20
Study: 19717547

Group type: EXPERIMENTAL
Intervention: 2000 IFN-alpha IU/day
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 1000 IFN-alpha IU/day
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 17092979

Group type: EXPERIMENTAL
Intervention: 5 mg/day donepezil
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 15596568

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SESs)
Number of subjects: 701

Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 701
Study: 11139914

Group type: EXPERIMENTAL
Intervention: Steroid-eluting coronary venous leads
Number of subjects: 58
Study: 9377534

Group type: EXPERIMENTAL
Intervention: Oxford Sleep Resistance test (OSLER test)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Maintenance of Wakefulness Test (MWT)
Number of subjects: 20
Study: 8436777

Group type: EXPERIMENTAL
Intervention: Budesonide (1600 micrograms/day for 14 days)
Number of subjects: 10
Study: 3759282

Group type: EXPERIMENTAL
Intervention: Nifedipine (20 mg every 6 h)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Verapamil (120 mg every 6 h)
Number of subjects: 22
Study: 31000010

Group type: EXPERIMENTAL
Intervention: Complete FFR-guided revascularization
Number of subjects: 280

Group type: COMPARATOR
Intervention: Culprit-only PCI
Number of subjects: 280
Study: 29548945

Group type: EXPERIMENTAL
Intervention: Ixekizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26906129

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Interpersonal communication with physicians
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Self-efficacy
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Involvement in treatment decision making
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Financial difficulty
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Social functioning
Number of subjects: 101
Study: 24581132

Group type: EXPERIMENTAL
Intervention: Group A (lower remifentanil concentration)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Group B (higher remifentanil concentration)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Group A and Group B (comparison of different remifentanil levels)
Number of subjects: 48
Study: 22609117

Group type: EXPERIMENTAL
Intervention: Multifactorial intervention program (individual advice, information leaflet, physical exercise workshop, home visits)
Number of subjects: 404

Group type: COMPARATOR
Intervention: Brief individual advice and information leaflet (Control Group)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Multifactorial intervention program
Number of subjects: 404
Study: 20714767

Group type: EXPERIMENTAL
Intervention: Ice-slush beverage (ISB)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Cool liquid beverage (CLB)
Number of subjects: 10
Study: 18843459

Group type: EXPERIMENTAL
Intervention: Enoxaparin 20 mg bid
Number of subjects: 832

Group type: EXPERIMENTAL
Intervention: Enoxaparin 20 mg qd
Number of subjects: 832

Group type: EXPERIMENTAL
Intervention: Enoxaparin 40 mg qd
Number of subjects: 832

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 832

Group type: EXPERIMENTAL
Intervention: All treatment groups (including placebo)
Number of subjects: 832
Study: 16091854

Group type: EXPERIMENTAL
Intervention: Going Places Program
Number of subjects: 1484
Study: 11821273

Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol (400 microg)
Number of subjects: 40
Study: 12153552

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg day-1
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 8
Study: 9649261

Group type: EXPERIMENTAL
Intervention: 5 mg finasteride daily for 9 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 40
Study: 8034082

Group type: EXPERIMENTAL
Intervention: Four fresh embryos transferred (group 1)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Two fresh embryos transferred and two frozen (group 2)
Number of subjects: 56
Study: 2688726

Group type: EXPERIMENTAL
Intervention: Fissure sealants
Number of subjects: 3005

Group type: COMPARATOR
Intervention: General dental practitioners
Number of subjects: 3005
Study: 30355640

Group type: EXPERIMENTAL
Intervention: Higher air leak measurements (≥100 mL/min on day 1)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Daily digital air leak measurements
Number of subjects: 81
Study: 28554908

Group type: EXPERIMENTAL
Intervention: B-type natriuretic peptide (BNP)
Number of subjects: 5525

Group type: EXPERIMENTAL
Intervention: N-terminal prohormone B-type natriuretic peptide (NT-proBNP)
Number of subjects: 5525

Group type: EXPERIMENTAL
Intervention: BNP or NT-proBNP
Number of subjects: 5525
Study: 26391136

Group type: EXPERIMENTAL
Intervention: Contact Force (CF) technology
Number of subjects: 1428

Group type: COMPARATOR
Intervention: Conventional catheter
Number of subjects: 1428
Study: 23737922

Group type: EXPERIMENTAL
Intervention: Student peer teacher
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Senior lecturer
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control group (students who never examined a child before)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Practical skills OSCE
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Peer teaching evaluation
Number of subjects: 123
Study: 21907539

Group type: EXPERIMENTAL
Intervention: Disengagement from threat
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Engagement towards non-threat
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Disengagement from threat and re-engagement towards non-threat
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study: 21067018

Group type: EXPERIMENTAL
Intervention: Tablet Ciprofloxacin 500 mg
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Injection Ceftriaxone 500 mg
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Injection Spectinomycin 2 gm
Number of subjects: 300
Study: 16520452

Group type: EXPERIMENTAL
Intervention: Audiotape questionnaire
Number of subjects: 497

Group type: COMPARATOR
Intervention: Written questionnaire
Number of subjects: 497
Study: 14600930

Group type: EXPERIMENTAL
Intervention: Solid meal (100 g ground beef labelled with 25 MBq (99m)Tc sulphur colloid)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Liquid meal (150 ml 10% glucose drink labelled with 8 MBq (67)Ga citrate)
Number of subjects: 23
Study: 10680096

Group type: EXPERIMENTAL
Intervention: Autogenic drainage (AD)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Active cycle of breathing techniques (ACBT)
Number of subjects: 30
Study: 9342984

Group type: EXPERIMENTAL
Intervention: Labetalol hydrochloride 0.3 mg/kg 3 minutes before induction and 0.15 mg/kg 2 minutes prior to suspension of the larynx
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Esmolol hydrochloride 500 micrograms/kg 3 minutes prior to induction and continuous infusion of 300 micrograms/kg during surgery
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group received only anesthetic drugs
Number of subjects: 30
Study: 8409786

Group type: EXPERIMENTAL
Intervention: Chiropractic Biophysics Technique (CBP)
Number of subjects: 65
Study: 31736357

Group type: EXPERIMENTAL
Intervention: Udenafil 87.5 mg twice daily
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study: 30204655

Group type: EXPERIMENTAL
Intervention: AIRfr (airflow-restriction mask)
Number of subjects: 10
Study: 28366047

Group type: EXPERIMENTAL
Intervention: Video modeling parental training intervention delivered over 22 weeks.
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 67
Study: 26009913

Group type: EXPERIMENTAL
Intervention: Conical interface (CI)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Flat-to-flat interface (FI)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Platform switch interface (PS)
Number of subjects: 141
Study: 23218805

Group type: EXPERIMENTAL
Intervention: Cognitive Bias Modification (CBM)
Number of subjects: 509

Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 509
Study: 22016911

Group type: EXPERIMENTAL
Intervention: GUM Summit+Compact Head
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: GUM Technique Deep Clean Compact Head
Number of subjects: 24

Group type: COMPARATOR
Intervention: Oral‐B Indicator 35 (compact head)
Number of subjects: 24
Study: 20120794

Group type: EXPERIMENTAL
Intervention: Multiple micronutrient supplements
Number of subjects: 0

Group type: COMPARATOR
Intervention: Iron with or without folic acid
Number of subjects: 0
Study: 17091657

Group type: EXPERIMENTAL
Intervention: Popsicle
Number of subjects: 0

Group type: COMPARATOR
Intervention: Toy
Number of subjects: 0